Hers vs RxActivate: Wegovy pricing vs gated pricing flow
Quick verdict: Hers vs RxActivate for GLP-1 weight-loss care
The primary difference in this comparison is pricing transparency. Hers lists FDA-approved Wegovy starting at $149/mo and requires an active membership; RxActivate requires a two-minute eligibility questionnaire and hides pricing and plan details behind a contact-information gate. Early verdict: choose Hers if you prioritize an advertised starting price and brand-name, noncompounded Wegovy; choose RxActivate if you are comfortable revealing contact details to learn whether you are eligible and to see pricing.
How pricing and transparency differ
Hers publishes a starting price: Wegovy pill from $149/mo and injectable from $199/mo, with a note that price includes medication only if prescribed and that an active Hers Weight Loss Membership is required. By contrast, RxActivate does not display any price, medication fee, membership fee, shipping charge, cancellation term or billing commitment before the contact-information gate. Pricing is gated behind completion of the medical eligibility questionnaire and submission of name, email and phone number.
Start RxActivate eligibility flow
Top differences at a glance
| Criteria | Hers | RxActivate |
|---|---|---|
| Pricing visibility | Wegovy pill from $149/mo; injectable from $199/mo; prices include medication only if prescribed | Pricing not shown; gated until contact info submitted |
| Medication type | FDA-approved Wegovy brand-name semaglutide; no compounded medications offered | Clinician-matched GLP-1 plans; medication-specific approval status must be confirmed |
| Intake flow | Membership required for medication; membership and medication billed separately | Two-minute eligibility questionnaire requests goals, history and state; Alabama service confirmed in test |
| Membership and billing | Active Hers Weight Loss Membership required ($39 first month, auto-renews at $149/month thereafter); medication not available without membership | No payment requested before contact-information step; billing terms not disclosed pre-contact |
| Claims and outcomes | Advertising includes outcome examples but prescription is not guaranteed; treatment available only when a licensed clinician determines it is medically appropriate | Provider-published outcome claims are not independent evidence; treatment available only when a licensed clinician determines it is medically appropriate |
View Hers membership and plans
Medication approval and compounding
Hers emphasizes FDA-approved brand-name Wegovy and states it is not a compounded product. The provider notes that compounded medications, when offered elsewhere, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. RxActivate notes that medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable. Both state that treatment is available only when a licensed clinician determines it is medically appropriate.
Intake process and state availability
RxActivate’s intake requests goal, height, weight, target weight, timeline, medication history, sex assigned at birth, date of birth, state and safety screening and displayed Alabama as serviceable in a synthetic test. Hers flags that not all services are available in all 50 states and that clinical eligibility criteria apply. If state availability is a deciding factor, the evidence supplied shows RxActivate confirmed Alabama in testing and Hers warns of limited state availability.
Pros and cons summary
Hers pros: FDA-approved brand-name Wegovy, personalized care team with ongoing dose check-ins, no compounded medications. Hers cons: Membership required and higher starting price than some compounded competitors; medication not available without active membership. RxActivate pros: Two-minute eligibility questionnaire, clinician-matched plans, no payment requested before contact-information step. RxActivate cons: Pricing requires personal contact information and fees are not disclosed before lead capture.
Conclusion: Hers vs RxActivate
Hers vs RxActivate splits along transparency and product type. Hers lists Wegovy starting at $149/mo and positions brand-name, noncompounded medication with a membership requirement. RxActivate requires an eligibility flow and contact information before showing pricing or plan details. Use the primary keyword when comparing the two: Hers vs RxActivate highlights whether you prefer upfront pricing and branded Wegovy or a gated eligibility and clinician-matching process.
Choose Hers to review Wegovy options
Choose Provider guidance
Choose Hers if you want an advertised starting price for FDA-approved Wegovy, prefer brand-name semaglutide and accept the required Hers Weight Loss Membership. Choose RxActivate if you are willing to complete a two-minute eligibility questionnaire and submit contact information to see clinician-matched plans, pricing and eligibility details.